Stonepath Group Inc. (SGRZ) Financials Nov 4, 2014, 12:00

New Post Public Reply Private Reply Replies (0) Message Board
Hirata
Stonepath Group Inc. (SGRZ) Financials Nov 4, 2014, 12:00 a.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Stonepath Group Inc.


Fiscal year is January-December. All values USD millions. 2001 2002 2003 2004 2005 5-year trend
Sales/Revenue 15.6M 139.65M 220.3M 367.08M 410.26M
Cost of Goods Sold (COGS) incl. D&A 15.2M 120.43M 156.38M 331.54M 374.43M
COGS excluding D&A 14.97M 119.43M 153.72M 327.35M 370.11M
Depreciation & Amortization Expense 232,000 1M 2.66M 4.19M 4.32M
Depreciation - - - - -
Amortization of Intangibles - - - - -
Gross Income 400,000 19.22M 63.93M 35.55M 35.82M
2001 2002 2003 2004 2005 5-year trend
SG&A Expense 4.69M 15.68M 56.47M 36.75M 36.43M
Research & Development - - - - -
Other SG&A 4.69M 15.68M 56.47M 36.75M 36.43M
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 0 1.17M 4.37M 3.28M
EBIT after Unusual Expense 0 0 (1.17M) (4.37M) (3.28M)
Non Operating Income/Expense 13,000 37,000 85,000 (3.07M) 962,179
Non-Operating Interest Income 1.29M 91,000 49,000 61,964 34,762
Equity in Affiliates (Pretax) - - - - -
Interest Expense 4,000 0 142,000 639,491 3.54M
Gross Interest Expense 4,000 0 142,000 639,491 3.54M
Interest Capitalized 0 0 0 0 0
Pretax Income (2.99M) 3.67M 6.28M (9.23M) (6.44M)
Income Tax 0 102,000 (1.31M) 2.4M 1.92M
Income Tax - Current Domestic 0 102,000 263,000 109,337 120,000
Income Tax - Current Foreign 0 0 121,000 1.67M 519,035
Income Tax - Deferred Domestic 0 0 (1.75M) 615,300 946,800
Income Tax - Deferred Foreign 0 0 50,000 0 332,000
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (2.99M) 3.57M 7.59M (11.62M) (8.35M)
Minority Interest Expense 0 0 187,000 1.39M 1.38M
Net Income (2.99M) 3.57M 7.4M (13.02M) (9.74M)
Extraordinaries & Discontinued Operations 13.86M 16.97M (263,000) (25,000) 0
Extra Items & Gain/Loss Sale Of Assets 13.86M 16.97M 0 0 0
Cumulative Effect - Accounting Chg 0 - - - -
Discontinued Operations - - (263,000) (25,000) 0
Net Income After Extraordinaries 10.87M 20.54M 7.14M (13.04M) (9.74M)
Preferred Dividends 4.15M 1.95M 0 0 35,918
Net Income Available to Common (7.15M) 1.61M 7.4M (13.02M) (9.77M)
EPS (Basic) (0.34) 0.07 0.24 (0.33) (0.22)
Basic Shares Outstanding 20.51M 22.15M 29.63M 38.97M 43.59M
EPS (Diluted) (0.35) 0.06 0.19 (0.33) (0.21)
Diluted Shares Outstanding 20.51M 29.23M 39.06M 38.97M 46.76M
EBITDA (4.06M) 4.54M 10.12M 2.98M 3.72M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 3

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 6

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 3

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 4

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading

Top 5 Most Recently Viewed Articles

Celcuity Inc. Prepares for Third Quarter Financial Results

Updated Category News Views 91

Celcuity Inc. Announces Upcoming Financial Results Release Celcuity Inc. (NASDAQ: CELC), a pioneering biotechnology company focused on innovative oncology therapies, has exciting news. The company will be releasing its financial results for the third quarter of 2025 after the market closes. This significant event is scheduled for a Wednesday, with management set to...

Continue Reading
EverTrue and DonorSearch Team Up to Revolutionize Fundraising

Updated Category News Views 973

EverTrue's Strategic Acquisition of DonorSearch EverTrue, a leader in donor engagement and pipeline development, recently announced a significant acquisition. The company has acquired DonorSearch, known for its innovative AI-powered donor discovery solutions. This strategic move is aimed at enhancing the capabilities of fundraising teams, enabling them to connect with...

Continue Reading
Celebrating Creativity and Inclusion: ADCOLOR Awards 2025

Updated Category News Views 315

ADCOLOR Awards 2025: A Night of Inspiration and Celebration Presented by leading organizations in the industry like Amazon, Disney, and Meta, the ADCOLOR Awards is a prestigious event celebrating remarkable individuals and organizations that champion diversity and inclusion in creative fields. This year's ceremony showcased inspiring figures such as Richelieu Dennis,...

Continue Reading
Transforming a $1000 Investment in First Solar to $3700

Updated Category News Views 161

Transform Your Investment with First Solar First Solar (NASDAQ: FSLR) has shown impressive performance over the past decade. This company has not only managed to keep pace with the market but has actually outperformed it by an average of 2.49% annually. This impressive annualized return translates to an average annual growth of 14.22%, making First Solar a notable player...

Continue Reading
Carpenter Technology Announces New Quarterly Dividend Plans

Updated Category News Views 107

Carpenter Technology Announces Quarterly Cash Dividend Carpenter Technology Corporation (NYSE: CRS), a leading name in high-performance specialty alloys, has made a significant announcement regarding its quarterly cash dividend. The company's Board of Directors has declared a dividend of $0.20 per share on common stock, underscoring its commitment to returning value to...

Continue Reading